From: A ROS-responsive polymeric prodrug nanosystem with self-amplified drug release for PSMA (−) prostate cancer specific therapy
Nanoparticles
Size (nm)
PDI
Zeta (mV)
DLC of DOX (%)
DLC of α-TOS (%)
DEE of α-TOS (%)
ATD-NPs
141
0.27
− 27.2
19.7
9.4
91.2
TD-NPs
106
0.23
− 13.5
20.8
9.8
93.5
AD-NPs
125
0.28
− 24.7
22.4
–